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ABSTRACT	 	Acne	 is	 a	 chronic,	 self-limiting,	 inflammatory	 disease	 of	 adolescents	 and	 young	 adults.	 Acne	 and	 its	associated	 problems	 affects	 as	many	 as	 80%	 of	 adolescents	 and	 young	 adults.	 Only	 one	 third	 affected	teenagers	could	consult	with	their	physician	about	acne.	Clindamycin	is	a	lincosamide	antibiotic,	developed	in	 1966	 by	 chemically	 modifying	 the	 naturally	 occurring	 lincomycin..	 Topical	 antibiotics	 such	 as	erythromycin	and	clindamycin	are	the	most	popular	in	the	management	of	acne.	Side	effects	though	minor	includes	erythema,	peeling,	dryness,	and	burning,	pseudomembranous	colitis	which	is	rare,	but	has	been	reported	itching,	with	clindamycin	.The	objective	of	the	study	is	to	evaluate	efficacy	of	topical	clindamycin	in	treating	acne	among	students	and	to	monitor	the	adverse	effects	encountered	during	the	therapy.	It	was	a	cross-sectional	questionnaire	study	carried	out	among	55	students	of	both	sex	group	of	age	varying	from	18	to	25	years	suffering	from	acne.	Knowledge	of	safe	and	effective	use	of	clindamycin	among	students	was	to	be	assessed	with	a	17	pre-validated	questionnaire	and	the	data	is	analyzed	using	descriptive	statistics.	Among	the	respondents,	about	79.6%	had	an	outbreak	of	acne.71.4%	believe	that	their	acne	is	due	their	food	habits.	87%	are	using	clindamycin	and	was	effective	in	76.7%.	Among	them,	about	61.9%	use	without	prescription	and	48.8%	claimed	to	have	no	side	effect	and	patients	without	recurrence	is	55%.This	study	is	to	demonstrate	the	efficacy	of	clindamycin	in	the	treatment	of	moderate	to	severe	acne.	The	relevant	data	obtained	through	this	study	will	help	to	aware	about	safe	and	effective	use	clindamycin	in	acne	patients	and	provides	information	about	the	perception	of	acne	among	young	adults	with	or	without	acne.		
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INTRODUCTION	Acne	vulgaris	is	a	chronic,	self-limiting,	inflammatory	disease	 of	 the	 pilosebaceous	 unit	 characterized	 by	pleomorphic	lesions	like	comedones,	erythromatous	
papules,	pustules,	cysts	and	nodules[1].	Although	the	course	of	acne	may	be	self-limiting,	the	sequelae	can	be	 lifelong,	 with	 pitted	 or	 hypertrophic	 scar	 for-mation[2].	 It	 is	 more	 common	 and	 more	 severe	 in	males	than	in	females,	relating	it	to	androgen	activity.	It	starts	at	puberty	or	a	few	months	earlier.	The	peak	incidence	is	between	14-17	years	in	women	and	16–19	years	in	men.	It	seems	to	be	famililial,	but	owing	to	the	high	prevalence	of	the	disease	this	has	been	ex-tremely	 difficult	 to	 assess.	 Nodulocystic	 acne	 has	been	 reported	 to	 be	more	 common	 in	white	males	than	 in	black	males,	and	one	group	of	 investigators	has	 found	that	acne	 is	more	severe	 in	patients	with	the	XYY	genotype.	Depending	on	the	severity	and	ex-tent	of	 involvement,	 treatment	varies	 from	applica-tion	of	topical	medications	to	systemic	therapy	with	antibiotics	 or	 retinoids[3].	 Various	 clinical	 presenta-tions	include	seborrhoea,	comedones,	erythematous	papules	and	pustules,	 less	 frequently	nodules,	deep	pustules	or	pseudocysts,	and	ultimate	scarring	in	few	of	them.	Acne	has	four	main	pathogenetic	mechanism	increased	sebum	productions,	 follicular	hyperkerat-inization,	Propionibacterium	acne	 (P.	acne)	coloniza-tion,	and	the	products	of	inflammation.[4–7]	In	recent	
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years,	due	to	better	understanding	of	the	pathogene-sis	 of	 acne,	 new	 therapeutic	 modalities	 are	 de-signed[5].	Topical	acne	therapies	are	widely	used	for	the	treatment	of	mild	to	moderately	severe	acne	vul-garis.	However,	many	available	treatments	have	lim-itations	associated	with	 their	use,	 including	 lengthy	time	 to	response,	cosmetic	acceptability	and	photo-sensitivity[8].	Topical	 treatment	 is	 sufficient	 in	most	patients	with	acne,	but	systemic	therapy	is	required	inpatients	 who	 have	 deep	 acne	 with	 nodules	 and	cysts.	The	major	topical	agents	now	in	use	are	vitamin	Aderivatives	and	antimicrobials	such	as	benzoyl	per-oxide	 and	 topical	 antibiotics.	 The	 topical	 retinoid	class,	 which	 includes	 tretinoin,	 adapalene	 and	tazarotene,	and	the	topical	antibacterials,	clindamy-cin	and	erythromucin,	are	regulated	by	prescription	in	most	 countries.	 Topical	 clindamycin	 has	 no	 sys-temic	toxicity	except	diarrhea	rarely	and	there	have	been	 2	 cases	 of	 pseudo	 membranous	 colitis	 re-ported10.Though	topical	clindamycin	is	being	used	in	many	countries	for	the	treatment	of	acne	vulgaris	but	it	was	not	being	used	in	our	country	due	to	non-avail-ability	of	the	drug[11].	
METHODOLOGY	It	was	a	cross-sectional	type	of	descriptive	study	car-ried	out	among	55	suffering	from	acne	vulgaris	in	col-lage	 students.	 It	 was	 carried	 out	 for	 a	 period	 of	 8	weeks.	 Knowledge	 of	 safe	 and	 effective	 use	 of	clindamycin	 among	 students	 were	 to	 be	 assessed	with	a	17	pre-validated	questionnaire	and	the	data	is	analyzed	 using	 descriptive	 statistics	 and	 include	questions	of	history	of	acne	regarding	duration,	hor-monal	 therapy,	 sun	 exposure,	 food	 habit	 and	 cos-metic	use	were	taken.	Patients	were	asked	about	pre-vious	use	of	clindamycin	and	any	hypersensitivity	to	these	agents.	Family	history	of	acne	was	also	taken.	
Inclusion	criteria:	Acne	patient	of	both	sex	group	of	age	varies	from	18	to	25	years.	
Exclusion	criteria:	Acne	patient	of	both	sex	group	of	age	below	18	and	above	25	years.	Patients	those	who	refused	to	be	included	in	the	study.	
Data	 collection:	 Data	 were	 collected	 during	 the	2018–2019	academic	year.	Questionnaires	were	dis-tributed	to	80	pharmacy	students.	Fifty	five	students	completed	the	questionnaire,	with	a	response	rate	of	79%.	Among	these	individuals,	males	were	13	and	fe-males	 were	 42.	 The	 participants	 from	 each	 course	ranged	between	23–96	students:	91	(38.3%)	pharm	D,	 23	 (9.7%)	 M	 pharm,	 96	 (40.5%)	 B	 pharm,	 27	(11.3%)	D	pharm.	All	the	participants	were	between	the	 age	 group	 18-25.	 Respondents	 completed	 the	online	 structured	 questionnaire	 forms	 which	 com-posed	of	check	box	questions	regarding	socio-demo-graphic	data,	food	habits,	skin	types,	cause	of	acne	in	their	 own	 perception,	 treatment,	 and	 duration	 of	therapy	etc.	Self	medication	practice	and	various	side	effect	of	therapy	were	recorded.	
Statistical	analysis:	All	data	collected	were	analyzed	using	both	descriptive	and	inferential	statistics.	The	data	were	analyzed	using	descriptive	statistics	for	de-mographic	 characteristics,	 food	 habits,	 skin	 types,	cause	of	acne	in	their	own	perception,	treatment,	du-ration	of	therapy.	Self-medication	practice	and	vari-ous	side	effect	of	therapy	were	analysed	and	the	value	of	P	<	0.05	was	considered	statistically	significant		
RESULTS	Among	 the	 total	 strength	450,	Questionnaires	were	distributed	randomly	to	80	pharmacy	students,	about	55	students	participated	in	the	survey	through	google	form,	 with	 a	 response	 rate	 of	 92%.	Within	 the	 re-spondents,	 All	 participants	 were	 between	 the	 age	group	 18-25.	 13	 were	 male	 and	 42	 were	 female.	Among	 the	 respondents,	 about	 79.6%	 had	 an	 out-break	of	acne	and	those	with	duration	of	acne	in	1-3	years	was	38%.	71.4%	believe	that	their	acne	is	due	their	food	habits.	87%	are	using	clindamycin	and	was	effective	 in	 76.7%	 (Figure	 1).	 Among	 them,	 about	61.9%	use	without	prescription	(Figure	2)	and	48.8%	claimed	 to	have	no	side	effect	and	patients	without	recurrence	is	55%.	The	objective	of	the	study	is	not	only	 to	 find	 out	 the	 efficacy	 of	 clindamycin	 given	orally,	but	also	to	find	out	if	this	efficacy	is	obtained	without	producing	the	adverse	effects	for	which	the	administration	 of	 Clindamycin	 is	 hesitated	 the	 ant-microbial.	
 
Figure 1: Treatment effectiveness	
 
Figure 2: A) Self medication pattern. 
B) Recurrence after the stoppage of the drug	
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Figure 3: A) Cause of acne in your own perception 
B) List of allopathic medicines 
C) Possible side effects of clindamycin.	
Table 1: Duration of Acne of study population 
Duration Number Percentage 
<6 month 7 13% 
1year 14 25% 
1-3year 21 38% 
>3year 2 3.6% 	
DISCUSSION	Acne	vulgaris	is	a	very	common	skin	disease	world-wide.	It	is	associated	with	the	high	probability	of	ad-verse	cosmetic	and	psychosocial	effects.	The	most	ef-fective	 treatment	 options	 for	 acne	 is	 clindamycin	therapy.		In	this	study	overall	response	to	topical	clindamycin	in	the	treatment	of	acne	vulgaris	has	been	observed.	This	12	week	study	found	Clindamycin	to	be	effective	in	the	treatment	of	acne,	with	reductions	in	the	num-ber	 of	 inflammatory	 and	 total	 acne	 lesions	 signifi-cantly.	It	is	safe	and	effective	topical	therapy	for	acne	vulgaris.	Clindamycin	is	widely	used	to	treat	acne	vul-garis.	Patients	using	the	1%	clindamycin	lotion	expe-rienced	 reductions	 in	 number	 of	 pustules,	 papules,	open	comedones	and	nodulocystic	lesions	However,	two	thirds	of	affected	teenagers	wish	that	they	could	speak	with	their	physician	about	acne,	but	only	one	third	actually	do.	Whereas	in	my	study	it	seems	that	clindamycin	alone	was	significantly	effective	in	mild	to	moderate	acne	vulgaris.	This	variation	may	be	be-cause	 they	 have	 used	 combination	 therapy	 of	clindamycin	 in	 their	 study	 while	 in	 my	 study	clindamycin	was	used	as	monotherapy.	In	this	study	only	 one	 patient	 reported	 irritation	 and	 burning	(3.33%).	 Similarly	 one	 patient	 developed	 pruritus	(3.33%),	 one	 patient	 complained	 of	 erythema	(3.33%)	,	and	one	patient	had	peeling	(3.33%).	Oily	skin	 was	 observed	 in	 two	 patients	 (6.67%).	 These	side	effects	are	minimum	and	insignificant.	The	clini-cal	side	effects	of	topical	clindamycin	described	in	the	literature	includes	facial	pruritus,	irritation	and	burn-ing,	 erythema,	 peeling,	 dryness,	 oily	 skin	 and	 diar-rhoea	rarely.	Only	2	cases	of	pseudomembranous	co-
litis	 reported.	 These	 symptoms	were	 of	mild	 inten-sity.	 Although	 diarrhoea	was	 reported	 in	 some	 pa-tients.	No	patients	discontinued	the	protocol	because	of	 diarrhea.	 All	 other	 adverse	 events	 were	mild	 or	moderate.	They	also	reported	moderate	facial	pruri-tus	 that	 resolved	without	 treatment	and	mild	 facial	pruritus	 and	 irritation	 that	 cleared	 without	 treat-ment.	In	this	study	overall	response	to	topical	clindamycin	in	the	treatment	of	acne	vulgaris	has	been	observed.	About	55	 students	were	 responded	 through	Google	forms.	Among	the	respondents,	about	79.6%	had	an	outbreak	of	acne.71.4%	believe	that	their	acne	is	due	their	food	habits.	87%	are	using	clindamycin	and	was	effective	 in	 76.7%.	 Among	 them,	 about	 61.9%	 use	without	prescription	and	48.8%	claimed	to	have	no	side	effect	 and	patients	without	 recurrence	 is	55%.	The	objective	of	the	study	is	not	only	to	find	out	the	efficacy	of	clindamycin	given	orally,	but	also	to	 find	out	 this	 efficacy	 is	 obtained	without	 producing	 the	adverse	effects	
CONCLUSION	Significance	of	the	study	is	to	confirms	that	clindamy-cin	 is	 safe	 and	 effective	 topical	 therapy	 for	mild	 to	moderate	 acne	 vulgaris	 with	minimum	 side	 effects	that	subside	with	continuation	of	the	therapy.	Proper	selection	 of	 patients	 as	 well	 as	 appropriate	 topical	use	of	the	drug	for	adequate	duration	will	often	result	in	 significant	 clinical	 improvement	 with	 infrequent	and	mild	adverse	effects	that	subside	with	continua-tion	of	the	therapy.	None	of	the	reactions	was	severe,	all	were	mild	and	well	 tolerated	and	most	occurred	within	the	first	month	of	initiation	of	treatment	and	resolved	with	continued	use	of	drug	and	completely	cured	after	the	treatment	completed.	No	body	had	to	discontinue	 the	 therapy	 for	side	effects.	80%	of	 the	total	patients	had	no	side	effects.	The	relevant	data	obtained	through	this	study	will	help	to	aware	about	safe	 and	 effective	 use	 clindamycin	 in	 acne	 patients	and	 provides	 information	 about	 the	 perception	 of	acne	among	young	adults	with	or	without	acne.		
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